![Takaaki Ishii](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Takaaki Ishii
Private Equity Investor at Taiho Ventures LLC
Profile
Takaaki Ishii, a molecular biologist by training, joined Taiho Ventures in 2019.
He has acquired over 11 years of oncology expertise in early stage clinical development, product portfolio strategies as well as scientific evaluations for in-house and potential partnering programs in a wide range of cancer types.
His representative contribution to Taiho Pharmaceutical includes in-licensing AB928 (A2aR/A2bR Dual Antagonist) from Arcus Biosciences as well as both medical and Medical Science Liaison activities for nab-paclitaxel (ABRAXANE®) and pembrolizumab (KEYTRUDA®) in Japan.
Takaaki Ishii active positions
Companies | Position | Start |
---|---|---|
Taiho Ventures LLC
![]() Taiho Ventures LLC Investment ManagersFinance Taiho Ventures LLC (Taiho Ventures) is a venture and private equity subsidiary of Taiho Pharmaceutical Co Ltd founded in 2016. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 2018-12-31 |
Training of Takaaki Ishii
Tokyo Institute of Technology | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Taiho Ventures LLC
![]() Taiho Ventures LLC Investment ManagersFinance Taiho Ventures LLC (Taiho Ventures) is a venture and private equity subsidiary of Taiho Pharmaceutical Co Ltd founded in 2016. The firm is headquartered in Menlo Park, California. | Finance |
- Stock Market
- Insiders
- Takaaki Ishii